Serum ApoA-IV levels of patients with pancreatic cancer (107.8 ± 99.9 AU) were significantly lower than those in healthy volunteers (195.2 ± 66.9 AU, P = 0.008) Figure 3(a). This evidence concerns the gene APOA4 and pancreatic neoplasm.